Abstract
The dissociating and/or residual inhibitory effects of bopindolol from β-adrenoceptors (ARs) of atria strips pretreated with this drug and washed out with buffers on isoprenaline-induced chronotropic actions were determined. The effects of this drug were compared with those of its active metabolite 18-502, propranolol, and pindolol. Our results are as follows: (1) Lower concentrations of bopindolol (10<sup>–9</sup> and 10<sup>–8</sup> mol/l) and the active metabolite 18-502 (10<sup>–9</sup> mol/l), propranolol (10<sup>–8</sup> and 10<sup>–6</sup> mol/l) and pindolol (10<sup>–8</sup> mol/l) produced rightward shifts of concentration-response curves of isoprenaline. (2) Higher concentrations of bopindolol (10<sup>–7</sup> mol/l) and 18-502 (10<sup>–8</sup> and 10<sup>–7</sup> mol/l) produced a reduced maximum response by isoprenaline. (3) Bopindolol (10<sup>–9</sup>–10<sup>–7</sup> mol/l), 18-502 (10<sup>–9</sup>–10<sup>–7</sup> mol/l) and propranolol (10<sup>–7</sup> and 10<sup>–6</sup> mol/l) did not recover to control levels at 180 min even after washout with buffers. In conclusion, bopindolol and 18-502 may slowly dissociate and act as noncompetitive β-antagonists rather than readily reversible β-AR antagonists. These effects may differ from those of propranolol and pindolol, although propranolol did not recover to control levels after washout with buffer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.